UK invests $13M+ in 17 biopharma manufacturers

2023-08-22

基因疗法

The UK is making a £13 million investment into 17 manufacturers dotted throughout the country.

The companies do a range of work, including manufacturing nucleic acid-based medicines, automating or digitalizing manufacturing efforts, or developing methods around intracellular drug delivery for vaccines. The funds come from Innovate UK, a public entity supporting technology and science businesses.

This includes contract manufacturer Rentschler Biopharma, which plans to implement analytical technologies to boost efficiency in the production of gene therapies. Rentschler recently built a cell and gene manufacturing site in Stevenage.

UK invests $13M+ in 17 biopharma manufacturers

Preview

来源: EndPoints

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构